-
Je něco špatně v tomto záznamu ?
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42)
H. Janíčková, V. Rudajev, P. Zimčík, J. Jakubík, H. Tanila, EE. El-Fakahany, V. Doležal,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- amyloidní beta-protein antagonisté a inhibitory metabolismus MeSH
- CHO buňky MeSH
- Cricetulus MeSH
- křečci praví MeSH
- kultivované buňky MeSH
- lidé MeSH
- myši transgenní MeSH
- myši MeSH
- peptidové fragmenty antagonisté a inhibitory metabolismus MeSH
- receptor muskarinový M1 metabolismus MeSH
- receptory spřažené s G-proteiny antagonisté a inhibitory metabolismus MeSH
- rozpřahující látky farmakologie MeSH
- vazba proteinů účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- křečci praví MeSH
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The overproduction of β-amyloid (Aβ) fragments in transgenic APPswe/PS1dE9 mice results in formation of amyloid deposits in the cerebral cortex and hippocampus starting around four months of age and leading to cognitive impairment much later. We have previously found an age and transgene-dependent weakening of muscarinic receptor-mediated transmission that was not present in young (6-10-week-old) animals but preceded both amyloid deposits and cognitive deficits. Now we investigated immediate and prolonged in vitro effects of non-aggregated Aβ(1-42) on coupling of individual muscarinic receptor subtypes expressed in CHO (Chinese hamster ovary) cells and their underlying mechanisms. Immediate application of 1 μM Aβ(1-42) had no effect on the binding of the muscarinic antagonist N-methylscopolamine or the agonist carbachol. In contrast, 4-day treatment of CHO cells expressing the M1 muscarinic receptor with 100 nM Aβ(1-42) significantly changed the binding characteristics of the muscarinic agonist carbachol and reduced the extent of the M1 receptor-stimulated breakdown of phosphatidylinositol while it did not demonstrate overt toxic effects. The treatment had no influence on the expression of either G-proteins or muscarinic receptors. In concert, we found no change in the gene expression of muscarinic receptor subtypes and gene or protein expression of the G(s), G(q/11), and G(i/o) G-proteins in the cerebral cortex of young adult APPswe/PS1dE9 mice that demonstrate high concentrations of soluble Aβ(1-42) and impaired muscarinic receptor-mediated G-protein activation. Our results provide strong evidence that the initial injurious effects of Aβ(1-42) on M1 muscarinic receptor-mediated transmissionis is due to compromised coupling of the receptor with G(q/11) G-protein.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14040970
- 003
- CZ-PrNML
- 005
- 20140114102829.0
- 007
- ta
- 008
- 140107s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuropharm.2012.11.014 $2 doi
- 035 __
- $a (PubMed)23206502
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Janíčková, Helena
- 245 10
- $a Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42) / $c H. Janíčková, V. Rudajev, P. Zimčík, J. Jakubík, H. Tanila, EE. El-Fakahany, V. Doležal,
- 520 9_
- $a The overproduction of β-amyloid (Aβ) fragments in transgenic APPswe/PS1dE9 mice results in formation of amyloid deposits in the cerebral cortex and hippocampus starting around four months of age and leading to cognitive impairment much later. We have previously found an age and transgene-dependent weakening of muscarinic receptor-mediated transmission that was not present in young (6-10-week-old) animals but preceded both amyloid deposits and cognitive deficits. Now we investigated immediate and prolonged in vitro effects of non-aggregated Aβ(1-42) on coupling of individual muscarinic receptor subtypes expressed in CHO (Chinese hamster ovary) cells and their underlying mechanisms. Immediate application of 1 μM Aβ(1-42) had no effect on the binding of the muscarinic antagonist N-methylscopolamine or the agonist carbachol. In contrast, 4-day treatment of CHO cells expressing the M1 muscarinic receptor with 100 nM Aβ(1-42) significantly changed the binding characteristics of the muscarinic agonist carbachol and reduced the extent of the M1 receptor-stimulated breakdown of phosphatidylinositol while it did not demonstrate overt toxic effects. The treatment had no influence on the expression of either G-proteins or muscarinic receptors. In concert, we found no change in the gene expression of muscarinic receptor subtypes and gene or protein expression of the G(s), G(q/11), and G(i/o) G-proteins in the cerebral cortex of young adult APPswe/PS1dE9 mice that demonstrate high concentrations of soluble Aβ(1-42) and impaired muscarinic receptor-mediated G-protein activation. Our results provide strong evidence that the initial injurious effects of Aβ(1-42) on M1 muscarinic receptor-mediated transmissionis is due to compromised coupling of the receptor with G(q/11) G-protein.
- 650 _2
- $a amyloidní beta-protein $x antagonisté a inhibitory $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a křečci praví $7 D006224
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a peptidové fragmenty $x antagonisté a inhibitory $x metabolismus $7 D010446
- 650 _2
- $a vazba proteinů $x účinky léků $x fyziologie $7 D011485
- 650 _2
- $a receptor muskarinový M1 $x metabolismus $7 D043643
- 650 _2
- $a receptory spřažené s G-proteiny $x antagonisté a inhibitory $x metabolismus $7 D043562
- 650 _2
- $a rozpřahující látky $x farmakologie $7 D014475
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rudajev, Vladimír $u -
- 700 1_
- $a Zimčík, Pavel $u -
- 700 1_
- $a Jakubík, Jan $u -
- 700 1_
- $a Tanila, Heikki $u -
- 700 1_
- $a El-Fakahany, Esam E $u -
- 700 1_
- $a Doležal, Vladimír $u -
- 773 0_
- $w MED00003497 $t Neuropharmacology $x 1873-7064 $g Roč. 67, č. - (2013), s. 272-83
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23206502 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140107 $b ABA008
- 991 __
- $a 20140114103533 $b ABA008
- 999 __
- $a ok $b bmc $g 1005366 $s 839482
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 67 $c - $d 272-83 $i 1873-7064 $m Neuropharmacology $n Neuropharmacology $x MED00003497
- LZP __
- $a Pubmed-20140107